ArticleScientific reports2021

Targeting galectin-3 with a high-affinity antibody for inhibition of high-grade serous ovarian cancer and other MUC16/CA-125-expressing malignancies.

Marina Stasenko et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.